Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00855556 · ClinicalTrials.gov registry record

Parkinson's Disease Genetics Database

A clinical trial, sponsored by Northwell Health.

Terminated
Registry status
16
Enrollment target

NCT00855556 is a clinical trial that was terminated before completion, run by Northwell Health. The registered enrollment target is 16 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00855556 was terminated before completion, sponsored by Northwell Health.

TERMINATED
Registry status
16 participants
Enrollment target

Study Summary

The goal of the study is to develop and organize an effort to identify genes that determine an individual's risk for developing Parkinson's disease (PD). 1. To ascertain, study and establish a repository of DNA samples that will allow for the identification of known and yet-to-be-identified genetic markers associated with the development of PD. 2. To create a database with clinical, genetic (HLA, genome screen) and medical history information that will facilitate the search for PD susceptibility genes. 3. To provide a centralized DNA repository to allow for targeted studies of genetic factors contributing to the onset, heterogeneity and progression of PD. 4. To evaluate opportunities to extend the results of research to develop methods of risk prediction, prevention and therapy for PD.

Interventions

  • GENETIC blood draw

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2008-02
Est. Completion 2013-02

Sponsor

Northwell Health

370 total trials

What the Registry Record Tells You About NCT00855556

The ClinicalTrials.gov registry entry for NCT00855556 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which blood draw is the first listed.

NCT00855556 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00855556 about?

NCT00855556 is a clinical study titled "Parkinson's Disease Genetics Database". The goal of the study is to develop and organize an effort to identify genes that determine an individual's risk for developing Parkinson's disease (PD). 1. To ascertain, study and establish a repository of DNA samples that will allow for the identification of known and yet-to-be-identified genetic...

What is the current status of trial NCT00855556?

This trial is currently terminated. The enrollment target is 16 participants. The study started on 2008-02. Estimated completion is 2013-02.

What interventions are being tested in trial NCT00855556?

The interventions under investigation include: blood draw (GENETIC).

Who is sponsoring clinical trial NCT00855556?

This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.